g-finder.

Global investments into neglected disease R&D

The G-FINDER project tracks and reports on global investments into research and development (R&D) for neglected diseases.

G-FINDER is a uniquely informative data source, providing policy-makers, donors, researchers and industry with an understanding of the landscape for neglected disease R&D, where funding gaps exist, and how their investments fit into the global picture.

G-FINDER is recognised as the gold standard in tracking and reporting global funding for neglected disease R&D as evidenced by:
– The World Health Organization (WHO) Expert Panel’s Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property includes a recommendation for Member States to commit to providing information to G-FINDER;
– The inclusion of G-FINDER as both a primary source and an indicator in agenda items presented at the 2018 WHO Executive Board meeting and World Health Assembly;
– The 2016 statement from Science and Technology Ministers of the G7 that G7 members should “develop and improve their national information systems in terms of coverage, completeness, consistency, and ease of use, with the goal to report the significant majority of their national, publicly funded R&D activities on PRDs/NTDs to G-FINDER and the World RePORT by 2018”; and
– G-FINDER’s use as the primary source of neglected disease R&D funding data for both the WHO Global Observatory on Health R&D and Donor Tracker

The G-FINDER report covers:
– 33 neglected diseases;
– across 142 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products; and
– platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)

The data includes all types of product-related R&D, including basic research, discovery and pre-clinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.

Funded by the Bill & Melinda Gates Foundation since inception, the G-FINDER project was originally hosted at The George Institute for International Health and then run by Policy Cures from 2010. Following the establishment of Policy Cures Research (PCR) as a separate organisations in 2016, the G-FINDER project is conducted by Policy Cures Research.

G-FINDER (public search tool)

The G-FINDER Public Search tool provides access to G-FINDER survey data. The Public Search Tool is updated annually and search results can be exported into Microsoft Excel for flexible data analysis.

Policy Cures Research G-FINDER Reports

G-FINDER 2018 Neglected Disease Research and Development: Reaching new heights

The eleventh G-FINDER report was launched Wednesday 23 January 2019, in Geneva, Switzerland

G-FINDER 2018 Report

– Full G-FINDER 2018 report
– Executive summary
– Introduction
– Findings – Neglected disease funding by disease
– Findings – Neglected disease funders
– Findings – Neglected disease funding flows
– Discussion
– Annexes

G-FINDER 2018 online resources:
– Neglected disease R&D matrix
– Methodology
– Scope document

G-FINDER 2017 Neglected Disease Research and Development: Reflecting on a decade of global investment

The tenth G-FINDER report was launched Wednesday 13 December 2017, in London, UK

G-FINDER 2017 Report


– Full G-FINDER 2017 report
– Introduction
– Findings – Neglected disease funding by disease
– Findings – Neglected disease funders
– Findings – Neglected disease funding flows
– Discussion
– Annexes
– Launch presentation

G-FINDER 2017 online resources:
– Neglected disease R&D matrix
– Methodology
– Scope document

Reports from our previous organisation

For older G-FINDER reports and associated publications produced prior to the separation of Policy Cures Research and Policy Cures into two organisations, please see: www.policycures.org/g-finder.html